![Nebulized liposomal amphotericin B for treating Aspergillus empyema with bronchopleural fistula. | Semantic Scholar Nebulized liposomal amphotericin B for treating Aspergillus empyema with bronchopleural fistula. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/87dd09b946d532f6e977b44665d5771216b8c140/1-Figure1-1.png)
Nebulized liposomal amphotericin B for treating Aspergillus empyema with bronchopleural fistula. | Semantic Scholar
![Inhaled Amphotericin B as Aspergillosis Prophylaxis in Hematologic Disease: An Update - Madison J Duckwall, Mark A Gales, Barry J Gales, 2019 Inhaled Amphotericin B as Aspergillosis Prophylaxis in Hematologic Disease: An Update - Madison J Duckwall, Mark A Gales, Barry J Gales, 2019](https://journals.sagepub.com/cms/10.1177/1178636119869937/asset/images/large/10.1177_1178636119869937-fig1.jpeg)
Inhaled Amphotericin B as Aspergillosis Prophylaxis in Hematologic Disease: An Update - Madison J Duckwall, Mark A Gales, Barry J Gales, 2019
![Nebulised surface-active hybrid nanoparticles of voriconazole for pulmonary Aspergillosis demonstrate clathrin-mediated cellular uptake, improved antifungal efficacy and lung retention | Journal of Nanobiotechnology | Full Text Nebulised surface-active hybrid nanoparticles of voriconazole for pulmonary Aspergillosis demonstrate clathrin-mediated cellular uptake, improved antifungal efficacy and lung retention | Journal of Nanobiotechnology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12951-020-00731-1/MediaObjects/12951_2020_731_Sch1_HTML.png)